The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation

PHASE4UnknownINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Schizophrenia
Interventions
DRUG

Ziprasidone

During the study, at least 1 injection is needed per day. Whether the second, third or fourth one is needed according to patients' symptoms. If the BARS score\>=5, clinicians are supposed to give 10mg or 20mg.If lower than 5, clinicians could choose to give 10mg or not according to patients' symptoms and doctor's experience. Doses of 10 mg may be administered every two hours; doses of 20 mg may be administered every four hours up to a maximum of 40 mg/day.It is not recommended to combine with other oral antipsychotic drugs. But if the patients' daily dose of injection has reached 40mg and agitation occurred 4 hours later after the last injection, with the BARS score higher than 5.The clinicians can determine whether or not to combine oral antipsychotic drug, and the dosage.

Trial Locations (1)

100096

Beijing Huilongguan Hospital, Beijing

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Yang Fude

OTHER

NCT02935998 - The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation | Biotech Hunter | Biotech Hunter